PMI is cleared of misleading investors over Japanese prospects for Iqos

Philip Morris International (PMI) did not deliberately mislead investors about clinical trials for its Iqos heated tobacco system or about the product’s prospects in Japan, a US federal court has ruled ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo